Whether occurring during embryonic development, in pathophysiological conditions, such as wound healing/tissue regeneration, or in fully pathological conditions, such as cancer and inflammatory diseases, angiogenesis is traditionally thought to be a strongly endothelium-driven process. In fact, the main features of the angiogenic model, largely preserved as first proposed by Folkman [1] in 1971, implicate endothelial cells as primary effectors of the tubulogenesis process [2]. As depicted in figure 1a, pro-angiogenic growth factors (especially VEGF) trigger endothelial cell activation, proliferation and motility. In addition to resident endothelial cells, circulating endothelial precursors may also participate in the formation of interconnected neotubules [3]. Another crucial role is played by local pericytes or bone marrow-derived pericyte progenitors [4-6]. According to the angiogenesis dogma, pericytes are recruited by migrating endothelial cells to confer stability to nascent vascular structures [2, 4-7]. Indeed, targeting pericytes through NG2 proteoglycan [8] or PDGFRβ [5, 6] strongly impacts neovasculogenesis and may also affect lymphangiogenesis.
Our recent observations suggest that the reduced levels of vascularization observed in pericyte targeting paradigms are due to a reversal of the roles proposed for endothelial and pericytic cells in the traditional model (fig. 1a). During normal angiogenesis in fetal human brain (fig.1b-d) [8], in murine tumor models (fig. 1e-g) [9], in subcutaneous Matrigel plug assays and in adult mouse cornea [7], cord-like structures composed solely of pericytes are observed at the sprouting front (see also online suppl. fig. S1; www.karger.com/doi/10.1159/000109965). These cords appear to serve as guiding structures for the progressive invasion of endothelial cells to construct the mature vessel (see also suppl. video 1; www.karger.com/doi/10.1159/000109965).
A high-resolution microscopic imaging of fetal angiogenesis in human brain (fig. 1h, i) reveals that following disruption of the subendothelial basement membrane during sprouting, a new one appears to be laid down by early emigrating pericytes at the distal end of the sprouts and invest these cells [10, 11]. Closer examination of the angiogenic sprouts of fetal human brain further identifies mitotic endothelial cells at the proximal base of the sprout (fig. 1h, i) rather than at its distal end. This observation contrasts with the migration-proliferation relationship proposed for endothelial cells in the classical angiogenesis model: rather than undergoing division subsequent to their sprouting migration, endothelial cells proliferate prior to beginning their movement along pericyte cords. In summary, pericytes initiate sprouting by forming strands connecting to existing capillaries, and endothelial cells utilize these ‘cellular cables’ as guidance cues during their post-mitotic movement to complete vessel assembly. While preserving the crucial role of the intimate interplay between the two vascular cell types, repeatedly demonstrated to be crucial during vessel formation and maturation, the new paradigm assigns an un-precedented morphogenetic role to pericytes in the angiogenic process. The reversal of endothelial and pericytic cell roles during the initial phases of this phenomenon suggests that we reconsider the rationale of current anti-angiogenic therapies. Despite the promising clinical utility of interfering with VEGF signalling, combined [12] or selective pericyte targeting may prove more efficacious in abrogating unwanted neoscularization without causing vascular side effects.
Supplementary Material
References
- 1.Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186. doi: 10.1056/NEJM197111182852108. [DOI] [PubMed] [Google Scholar]
- 2.Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401–410. doi: 10.1038/nrc1093. [DOI] [PubMed] [Google Scholar]
- 3.Khurana R, Simons M. Endothelial progenitor cells: precursors for angiogenesis. Semin Thorac Cardiovasc Surg. 2003;15:250–258. doi: 10.1016/s1043-0679(03)70004-5. [DOI] [PubMed] [Google Scholar]
- 4.Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood. 2004;104:2084–2086. doi: 10.1182/blood-2004-01-0336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Song S, Ewald AJ, Stallcup WB, Werb Z, Bergers G. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005;7:870–879. doi: 10.1038/ncb1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ozerdem U, Alitalo K, Salven P, Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophtha lmol Vis Sci. 2005;46:3502–3506. doi: 10.1167/iovs.05-0309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nystrom HC, Lindblom P, Wickman A, Andersson I, Norlin J, Faldt J, Lindahl P, Skott O, Bjarnegard M, Fitzgerald SM, Caidahl K, Gan LM, Betsholtz C, Bergstrom G. Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries. Cardiovasc Res. 2006;71:557–565. doi: 10.1016/j.cardiores.2006.05.019. [DOI] [PubMed] [Google Scholar]
- 8.Von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res. 2006;312:623–629. doi: 10.1016/j.yexcr.2005.10.019. [DOI] [PubMed] [Google Scholar]
- 9.Ozerdem U, Stallcup WB. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis. 2004;7:269–276. doi: 10.1007/s10456-004-4182-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Virgintino D, Girolamo F, Errede M, Capobianco C, Robertson D, Stallcup WB, Perris R, Roncali L. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis. 2007;10:35–45. doi: 10.1007/s10456-006-9061-x. [DOI] [PubMed] [Google Scholar]
- 11.Ozerdem U, Stallcup WB. Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis. 2003;6:241–249. doi: 10.1023/B:AGEN.0000021401.58039.a9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pietras K, Hanahan D. A multitargeted, metronomic, and maximum-tolerated dose ‘chemo-switch’ regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol. 2005;23:939–952. doi: 10.1200/JCO.2005.07.093. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.